Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calvert Venture Fund was a pioneering venture capital fund managed by Calvert Investments, notable for being one of the first to apply socially responsible investing (SRI) and ESG criteria to the venture capital asset class. The fund primarily targeted early-stage companies in the Mid-Atlantic region, with a strong focus on the healthcare, biotechnology, and environmental technology sectors. It sought to support innovative companies that demonstrated high growth potential alongside a commitment to positive social or environmental impact. Structured as a publicly traded mutual fund, it allowed individual investors to participate in venture capital, a rarity in the industry. The fund is no longer active, having been liquidated or merged as part of broader corporate transitions within the Calvert Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calvert Venture Fund.